Find A Physician
More on PGY-1 Pharmacy
More on PGY-1 Pharmacy
Research and Clinical Trials
More on PGY-1 Pharmacy
More on PGY-1 Pharmacy
The Post Graduate Year 1 (PGY-1) pharmacy residency program at NewYork-Presbyterian Hospital is an ASHP accredited 12-month, full-time program that begins in July. It is designed to provide pharmacy professionals with the knowledge and skills required to become leading clinicians in a dynamic healthcare field. Residents will have the opportunity to work alongside leading researchers and clinicians at the forefront of pharmacy practice and medicine.
NewYork-Presbyterian Hospital offers four PGY-1 pharmacy residency positions. We offer a flexible program customized to each resident through our extensive clinical practice programs in adults and pediatrics including administration, critical care, drug information, infectious diseases, imednternal medicine, oncology, and solid organ transplantation (heart, lung, liver, kidney, pancreas). Competitive salary, benefits, and subsidized housing are provided.
The program consists of exposure to varying specialties through required and elective rotations. Residency rotations include:
- Required Rotations
- Orientation and Training - 4 weeks
- Drug Information - 4 weeks
- Internal Medicine - 4 weeks
- Critical Care - 4 weeks
- Infectious Diseases - 4 weeks
- Pediatrics - 4 weeks
- Practice Management - Longitudinal
- Medication Safety - Longitudinal
- Time Off
- Vacation - 10 days
- Professional Days - 5 days
- Holidays - 9 days
- Elective Rotations
- Academia - 4 weeks
- Burn Unit - 4 weeks
- Emergency Medicine - 4 weeks
- HIV/AIDS - 4 weeks
- Neonatal Intensive Care - 4 weeks
- Oncology/BMT - 4 weeks
- Pediatric Critical Care - 4 weeks
- Solid Organ Transplantation - 4 weeks (heart, lung, liver, kidney, pancreas)
Rotations in Detail: Required Rotations
This rotation is designed to allow for the development of the pharmaceutical approach to the critically ill patient. This will be accomplished by designing therapeutic regimens that incorporate the principles of evidence based medicine, implementing evidence based monitoring plans that effectively evaluate the patient's response to therapy, establishing a collaborative relationship with physicians and other health-care providers in the hospital, and participating in continuous adherence to the health-systems' medication use guidelines, policies, and procedures. The critical care rotation is offered in any of the following areas: Medical ICU, Surgical ICU, Cardiothoracic ICU, or Neurosciences ICU.
This rotation is designed to educate the resident on the function and role of a Drug Information Center in the setting of a large tertiary-care institution. The resident will be trained in effective methods of providing appropriate and applicable drug information to various members of the hospital community. Additionally, the resident will be oriented to the hospital network of committees and subcommittees overseeing the safe and appropriate use of medications and medication related issues. Upon completion of the rotation, the resident should be able to achieve proficiency in the use of all electronic and non-electronic resources for application in later rotations as well as understand the concepts of adverse drug reaction reporting and medication use evaluations.
This rotation will provide the resident with a general understanding of the etiology, pathophysiology, treatment, and prognosis of common infectious diseases. The resident will be working with the adult infectious disease consult service. The objective of this rotation is to develop the skills and competencies needed to provide quality pharmaceutical care in patients with infectious diseases. This will be accomplished by demonstrating a general knowledge of the anti-infective agents and their roles in the treatment of infectious diseases, by understanding the relationship between pharmacokinetics and pharmacodynamics of anti-infectives and how each relates to the selection of an appropriate drug therapy regimen, and by designing therapeutic regimens that incorporate the principles of evidence based medicine with a special emphasis on rational use and monitoring of anti-infective agents.
This rotation is designed to allow for the development of the pharmaceutical approach including understanding the etiology, pathophysiology, treatment, and prognosis of common internal medicine disease states. This will be accomplished through designing therapeutic regimens that incorporate the principles of evidence-based medicine and implementing evidence based monitoring plans that effectively evaluate the patient's response to therapy. The resident will be assigned to the care of patients followed by the adult internal medicine service.
The pediatric rotation is designed to allow for the development of the pharmaceutical approach to the general pediatric patient. Pediatric and adolescent patients have special pharmaceutical care needs because of the changes that occur as they mature. This is further complicated by the unavailability of reliable information regarding appropriate dosing. More than 75% of medications carry the FDA warning, safety and efficacy in children have not been established. Ethical, logistical and technical difficulties hamper conducting well-designed pediatric trials. This often times forces a clinician to extrapolate information from results obtained from adult trials. The need for adjustments in the dose and dosage interval changes as the child matures, resulting in the need for careful drug therapy and monitoring. These challenges and limitations will be discussed. Common pediatric disease states and drug therapy topics (such as the pharmacokinetic and pharmacodynamic differences between children and adults) will also be reviewed. Emphasis will be placed upon the rational use of drug therapy in the patient treatment plan.
The goal of this rotation is for the resident to gain an understanding in various administrative roles and management theories within a large teaching institution. The resident will be exposed to practice management, drug policy, drug acquisition, and pharmaceutical outcomes. Within these areas, concepts such as organizational structure, quality assurance, developing goals and strategies, evaluation of pharmacy services, and performance improvement will be reviewed. Other activities include budget and financing, purchasing and contracts, and compliance with regulatory agencies.
This rotation offers the resident the opportunity to develop knowledge and skills necessary to provide pharmaceutical care to burn patients. The resident will round daily with a multidisciplinary team that offers comprehensive treatment for the three phases of burn-injury care: burn shock, wound care/surgery, and rehabilitation/reconstruction. The William Randolph Hearst Burn Center at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is a 45-bed unit that treats more than 1,300 adult and pediatric inpatients annually.
The Emergency Medicine rotation offers the resident an opportunity to develop the knowledge and skills necessary to provide pharmaceutical care to patients in an emergent care situation. This will be accomplished through participation with the health care team by offering complete medication and allergy histories, drug and toxicology information, code participation, and medication selection.
This rotation is designed to provide an introductory experience to hematology/oncology patients comprising of acute and chronic leukemia, lymphomas, and various solid tumors, with the goal of developing the skills and competencies needed to provide good pharmaceutical care. The resident will be assigned to care for all of the patients on one of the Hematology/Oncology services while participating in daily rounds and managing the drug therapy of those patients.
This rotation will provide the resident with an introduction to the care of patients infected with HIV including a general understanding of HIV disease, antiretroviral therapy, and opportunistic infections. It will allow for the development of the skills and competencies needed to provide quality pharmaceutical care in patients with HIV. This will be accomplished by demonstrating a general knowledge of the natural history and lifecycle of HIV, by understanding the pharmacology of individual antiretrovirals and their use in combination regimens, by understanding the etiology, treatment, and prophylaxis of opportunistic infections, by designing therapeutic regimens that incorporate the principles of evidence based medicine with a special emphasis on rational use and monitoring, and by understanding the etiology and treatment of secondary problems seen in HIV patients. The resident will be assigned to the care of patients followed by the inpatient infectious diseases/HIV service at NewYork-Presbyterian Hospital/Columbia University Medical Center.
Neonatal Intensive Care
This elective rotation is designed to provide an introductory experience to the pharmaceutical care of the critically ill neonate. The goal of this rotation is for the resident to develop the skills and competencies in pharmaceutical care as it relates to neonates, enabling the resident to effectively participate in therapeutic decision making, drug therapy selection, and monitoring of this patient population.
Pediatric Intensive Care
This rotation is designed to allow the resident to build on the knowledge achieved during the general pediatric rotation and gain experience and proficiency in the pharmaceutical care of critically ill children ranging from newborns to older adolescents. Residents will be exposed to a wide variety of diagnoses including but not limited to trauma, postoperative care, and critically ill oncologic patients.
Solid Organ Transplantation
This rotation is designed to provide an introductory experience to the pharmaceutical approach to solid organ transplant recipients. The resident will be assigned to care for patients on one of the transplant services (heart, liver, or lung transplant services at Columbia University Medical Center; kidney/pancreas transplant service at Weill Cornell Medical Center) while participating in daily rounds and managing the drug therapy of those patients. Residents will become familiar with immunosuppressant pharmacotherapy as well as medical issues that surround a transplant patient. In addition, residents provide discharge counseling to transplant patients.
Applicants must have graduated from an accredited Doctor of Pharmacy (Pharm.D.) program and be eligible for licensure in New York State prior to beginning the residency.
NewYork-Presbyterian Hospital Residency Programs participate in the ASHP-associated Pharmacy Online Residency Centralized Application Service (PhORCAS) for applications and the National Matching Service (NMS) for the residency matching process. Required documents should be submitted through PhORCAS by January 8th. Required documents include:
- Letter of Intent
- Curriculum Vitae
More details on the use of PhORCAS can be found at ashp.org.
Paper applications may be accepted under unusual circumstances through special arrangement with the Residency Program Director.
- Adrianne Hewryk, Pharm.D.
- Program Director
- PGY-1- Pharmacy Residency Program
- Department of Pharmacy
- NewYork-Presbyterian Hospital/Weill Cornell
- 525 East 68th Street, Room K-04
- New York, NY 10065
- Phone: (212) 746-0744
- Fax: (212) 746-8506
- E-mail: email@example.com